These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. McCluggage WG; Shah R; Connolly LE; McBride HA Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982 [TBL] [Abstract][Full Text] [Related]
3. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Lugli A; Tzankov A; Zlobec I; Terracciano LM Mod Pathol; 2008 Nov; 21(11):1403-12. PubMed ID: 18587323 [TBL] [Abstract][Full Text] [Related]
4. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype. Tot T Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262 [TBL] [Abstract][Full Text] [Related]
5. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072 [TBL] [Abstract][Full Text] [Related]
6. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries. Groisman GM; Meir A; Sabo E Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551 [TBL] [Abstract][Full Text] [Related]
7. Immunoprofile of adenocarcinomas of the endometrium, endocervix, and ovary with mucinous differentiation. Park KJ; Bramlage MP; Ellenson LH; Pirog EC Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):8-11. PubMed ID: 18776815 [TBL] [Abstract][Full Text] [Related]
8. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma. Ortiz-Rey JA; Alvarez C; San Miguel P; Iglesias B; Antón I Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):142-6. PubMed ID: 15894926 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805 [TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Zhang PJ; Shah M; Spiegel GW; Brooks JJ Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):306-10. PubMed ID: 14663355 [TBL] [Abstract][Full Text] [Related]
11. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652 [TBL] [Abstract][Full Text] [Related]
12. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
13. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Mazziotta RM; Borczuk AC; Powell CA; Mansukhani M Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794 [TBL] [Abstract][Full Text] [Related]
14. Synchronous primary perianal Paget's disease and rectal adenocarcinoma: report of a hitherto undescribed phenomenon. Chanjuan Shi ; Argani P Int J Surg Pathol; 2009 Feb; 17(1):42-5. PubMed ID: 18499687 [TBL] [Abstract][Full Text] [Related]
15. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517 [TBL] [Abstract][Full Text] [Related]
16. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Park SY; Kim BH; Kim JH; Lee S; Kang GH Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593 [TBL] [Abstract][Full Text] [Related]
17. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma]. Yuan ZF; Shi HR; Sun HM; Li WC Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105 [No Abstract] [Full Text] [Related]
18. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens. Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351 [TBL] [Abstract][Full Text] [Related]
19. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693 [TBL] [Abstract][Full Text] [Related]
20. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets. Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]